ArticleCancer immunology, immunotherapy : CII2023

Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.

Wei-Wei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.